Comparative study on the antitumor effects of gemcitabine polybutylcyanoacrylate nanoparticles coupled with anti-human MUC1 and CA199 monoclonal antibodies on pancreatic cancer in vitro and in vivo.

Zhang, Lin; Hou, Yanhong; Li, Chunmei; Liu, Haorun; Wang, Yujing

Zhang, Lin; Hou, Yanhong; Li, Chunmei; Liu, Haorun; Wang, Yujing.

Afiliação

Zhang L; Department of Gastroenterology, The Eighth Medical Center, PLA General Hospital, Beijing 100091, China. Electronic address: stepinghuns2@aliyun.com.
Hou Y; Department of Gastroenterology, The Eighth Medical Center, PLA General Hospital, Beijing 100091, China. Electronic address: houyan211@sina.com.
Li C; Department of Gastroenterology, The Eighth Medical Center, PLA General Hospital, Beijing 100091, China.
Liu H; Department of Gastroenterology, The Eighth Medical Center, PLA General Hospital, Beijing 100091, China.
Wang Y; Department of Gastroenterology, The Eighth Medical Center, PLA General Hospital, Beijing 100091, China.

Arab J Gastroenterol ; 23(4): 263-269, 2022 Nov.

Article em En | MEDLINE | ID: mdl-35922259

Assuntos

Embucrilato; Neoplasias Pancreáticas; Animais; Camundongos; Humanos; Anticorpos Monoclonais; Gencitabina; Camundongos Nus; Neoplasias Pancreáticas/tratamento farmacológico; Mucina-1

Palavras-chave

CA199; MUC1; Nanoparticles; Pancreatic cancer; Targeted therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Embucrilato Limite: Animals / Humans Idioma: En Revista: Arab J Gastroenterol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google